Your browser doesn't support javascript.
SARS-CoV-2 Breakthrough Infection after mRNA-1273 Booster among CoronaVac-Vaccinated Healthcare Workers.
Santi, Theresia; Kamarga, Lina; De Samakto, Baringin; Jo, Juandy.
  • Santi T; Siloam Hospitals Lippo Cikarang, West Java, Indonesia.
  • Kamarga L; Siloam Hospitals Lippo Cikarang, West Java, Indonesia.
  • De Samakto B; Siloam Hospitals Lippo Cikarang, West Java, Indonesia.
  • Jo J; Department of Biology, Faculty of Science and Technology, Universitas Pelita Harapan, Banten, Indonesia.
Infect Chemother ; 54(4): 774-780, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-2201235
ABSTRACT
It remains unknown whether the Indonesian healthcare workers (HCWs) who had received two doses of CoronaVac vaccine and one dose of mRNA-1273 booster could be protected during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron wave. In total, 125 infection-naïve and 10 previously infected HCWs were recruited. The mRNA-1273 booster substantially increased titer of anti-SARS-CoV-2 spike protein receptor-binding domain antibodies. However, the monitoring revealed that 34 out of 125 infection-naïve (27.2%) and 3 out of 10 previously infected HCWs (30.0%) were infected during the Omicron wave. All infected HCWs were either asymptomatic or having mild coronavirus disease 2019 (COVID-19) and subsequently fully recovered, supporting the heterologous prime-boost strategy against COVID-19.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines / Variants Language: English Journal: Infect Chemother Year: 2022 Document Type: Article Affiliation country: Ic.2022.0075

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines / Variants Language: English Journal: Infect Chemother Year: 2022 Document Type: Article Affiliation country: Ic.2022.0075